$SVVC
Firsthand Technology Value Fund, Inc.

2024 Q1 Form 10-Q Financial Statement

#000143774924016607 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $2.815M $191.3K
YoY Change 1372.07% -90.12%
Cost Of Revenue $250.9K
YoY Change -57.1%
Gross Profit -$59.64K
YoY Change -104.41%
Gross Profit Margin -31.18%
Selling, General & Admin $117.5K
YoY Change -6.64%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $138.4K
YoY Change -6.47%
Operating Profit -$198.1K
YoY Change -116.46%
Interest Expense -$4.544M
YoY Change -46.87%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.742M
YoY Change -35.48%
Income Tax
% Of Pretax Income
Net Earnings -$1.092M -$4.742M
YoY Change -76.96% -35.48%
Net Earnings / Revenue -38.8% -2479.46%
Basic Earnings Per Share -$0.16 -$0.69
Diluted Earnings Per Share -$0.69
COMMON SHARES
Basic Shares Outstanding 6.893M 6.893M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.644K $3.342K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $182.8K
Other Receivables $0.00
Total Short-Term Assets $182.8K
YoY Change -98.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $35.36M
YoY Change -56.98%
Other Assets
YoY Change
Total Long-Term Assets $35.44M
YoY Change -56.96%
TOTAL ASSETS
Total Short-Term Assets $182.8K
Total Long-Term Assets $35.44M
Total Assets $4.747M $35.62M
YoY Change -86.67% -62.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $282.9K
YoY Change 625.44%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.753M
YoY Change 17.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.753M
Total Long-Term Liabilities $0.00
Total Liabilities $4.579M $9.753M
YoY Change -53.05% 13.75%
SHAREHOLDERS EQUITY
Retained Earnings -$176.6M
YoY Change
Common Stock $6.893K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.87M
YoY Change
Total Liabilities & Shareholders Equity $35.62M
YoY Change -62.89%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.092M -$4.742M
YoY Change -76.96% -35.48%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$121.00 -$60.00
YoY Change 101.67% -100.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$121.00 -60.00
Cash From Investing Activities
Cash From Financing Activities $0.00 0.000
Net Change In Cash -$121.00 -60.00
YoY Change 101.67% -100.09%
FREE CASH FLOW
Cash From Operating Activities -$121.00 -$60.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Cash Held In Foreign Currency Acquisition Cost
CashHeldInForeignCurrencyAcquisitionCost
2629 usd
CY2023 us-gaap Cash Held In Foreign Currency Acquisition Cost
CashHeldInForeignCurrencyAcquisitionCost
2629 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
191262 usd
CY2024Q1 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
3033703 usd
CY2024Q1 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
-2783427 usd
CY2024Q1 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-15.6759 pure
CY2023 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.031 pure
CY2019 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-0.0284 pure
CY2024Q1 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2023 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2022 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2021 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2020 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0.0802 pure
CY2019 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
-0.0991 pure
CY2024Q1 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-15.6759 pure
CY2023 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.1112 pure
CY2019 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-0.1275 pure
CY2024Q1 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
-15.6759 pure
CY2023 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.031 pure
CY2019 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.028 pure
CY2024Q1 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
15.8564 pure
CY2023 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0813 pure
CY2022 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
-0.2096 pure
CY2021 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0294 pure
CY2020 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0064 pure
CY2019 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0393 pure
CY2024Q1 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2023 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2022 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2021 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2020 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2019 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
-0.0033 pure
CY2024Q1 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
15.8564 pure
CY2023 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0813 pure
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.2096 pure
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0294 pure
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0064 pure
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.036 pure
CY2024Q1 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0 pure
CY2023 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.01 pure
CY2022 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.15 pure
CY2021 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.16 pure
CY2020 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.13 pure
CY2019 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.18 pure
CY2024Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133837406 usd
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
27.964 pure
CY2024Q1 us-gaap Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets
NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
26.964 pure
CY2024Q1 svvc Net Assets Percentage Of Net Assets
NetAssetsPercentageOfNetAssets
1 pure
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133967669 usd
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
6.93 pure
CY2023Q4 us-gaap Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets
NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
5.93 pure
CY2023Q4 svvc Net Assets Percentage Of Net Assets
NetAssetsPercentageOfNetAssets
1 pure
CY2011Q2 us-gaap Operations Commenced Date1
OperationsCommencedDate1
2011-04-18
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
333-168195
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3008946
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
150 Almaden Boulevard, Suite 1250
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95113
CY2024Q1 dei City Area Code
CityAreaCode
408
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
886-7096
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6893056
CY2024Q1 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2024Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133837406 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133967669 usd
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4695742 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8733779 usd
CY2024Q1 us-gaap Cash Held In Foreign Currency
CashHeldInForeignCurrency
2644 usd
CY2023Q4 us-gaap Cash Held In Foreign Currency
CashHeldInForeignCurrency
2765 usd
CY2024Q1 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
10421 usd
CY2023Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
8161 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
38374 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
63649 usd
CY2024Q1 us-gaap Assets
Assets
4747181 usd
CY2023Q4 us-gaap Assets
Assets
8808354 usd
CY2024Q1 us-gaap Management Fee Payable
ManagementFeePayable
277 usd
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
0 usd
CY2024Q1 us-gaap Incentive Fee Payable
IncentiveFeePayable
4183706 usd
CY2023Q4 us-gaap Incentive Fee Payable
IncentiveFeePayable
7183782 usd
CY2024Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
37504 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
13891 usd
CY2024Q1 svvc Accrued Consultation Fees
AccruedConsultationFees
43000 usd
CY2023Q4 svvc Accrued Consultation Fees
AccruedConsultationFees
43000 usd
CY2024Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
314774 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
307310 usd
CY2024Q1 us-gaap Liabilities
Liabilities
4579261 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7547983 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
167920 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
6893 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6893 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176770722 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176770722 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176609695 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175517244 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
167920 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2024Q1 us-gaap Shares Outstanding
SharesOutstanding
7016432
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
7016432
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123376
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123376
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.02
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2024Q1 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
32045 usd
CY2024Q1 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
33703 usd
CY2023Q1 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
192820 usd
CY2024Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
29026 usd
CY2023Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
28503 usd
CY2024Q1 us-gaap Custody Fees
CustodyFees
1043 usd
CY2023Q1 us-gaap Custody Fees
CustodyFees
2160 usd
CY2024Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
5404 usd
CY2023Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
7878 usd
CY2024Q1 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
8813 usd
CY2023Q1 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
8704 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
67815 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
65769 usd
CY2024Q1 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
21037 usd
CY2023Q1 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
14548 usd
CY2024Q1 us-gaap Trustee Fees
TrusteeFees
36113 usd
CY2023Q1 us-gaap Trustee Fees
TrusteeFees
18750 usd
CY2024Q1 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
27509 usd
CY2023Q1 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
29288 usd
CY2024Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
19813 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
20931 usd
CY2024Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
250276 usd
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
389351 usd
CY2023Q1 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
-0 usd
CY2023Q1 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
389351 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
2815472 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
-198089 usd
CY2024Q1 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
0 usd
CY2023Q1 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-7864997 usd
CY2024Q1 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-3907923 usd
CY2023Q1 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
3320862 usd
CY2024Q1 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-3907923 usd
CY2023Q1 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-4544135 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1092451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4742224 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1092451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4742224 usd
CY2024Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
100000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
498424 usd
CY2024Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-30114 usd
CY2023Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
282470 usd
CY2024Q1 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
2260 usd
CY2023Q1 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
168314 usd
CY2024Q1 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
277 usd
CY2023Q1 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
10000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-3000076 usd
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
222107 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25275 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8563 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
31077 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-73157 usd
CY2024Q1 us-gaap Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-0 usd
CY2023Q1 us-gaap Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-7864997 usd
CY2024Q1 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-3907923 usd
CY2023Q1 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
3320862 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-121 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2765 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3404 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2644 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3342 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
2815472 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
-198089 usd
CY2024Q1 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
0 usd
CY2023Q1 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-7864997 usd
CY2024Q1 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-3907923 usd
CY2023Q1 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
3320862 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1092451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4742224 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1092451 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4742224 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
167920 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
25867367 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-0
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-0
CY2024Q1 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0
CY2023Q1 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.75
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.82
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.7
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.69
CY2024Q1 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.41
CY2023 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.16
CY2022 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
-1.81
CY2021 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.44
CY2020 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.09
CY2019 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.9
CY2024Q1 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2023 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2022 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2021 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2020 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2019 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
-0.08
CY2024Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.41
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-1.81
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.44
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.09
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.82
CY2024Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.57
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-4.42
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-7.5
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.51
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-2.3
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-12.15
CY2024Q1 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2023 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2022 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2021 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2020 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
-1.13
CY2019 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
2.34
CY2024Q1 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-0.57
CY2023 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-4.42
CY2022 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-7.5
CY2021 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-1.51
CY2020 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-3.43
CY2019 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-9.81
CY2024Q1 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.16
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-4.26
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-9.31
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.07
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-3.34
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-8.99
CY2024Q1 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2019 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2024Q1 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2023 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2022 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2021 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2020 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0.46
CY2019 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.02
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.75
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.82
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.7
CY2024Q1 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.26
CY2023Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.3
CY2022Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.95
CY2021Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
4.01
CY2020Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
4.47
CY2019Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
6.43
CY2024Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.8889 pure
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.9595 pure
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.6771 pure
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0722 pure
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1627 pure
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.3368 pure
CY2024Q1 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.1333 pure
CY2023 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.6842 pure
CY2022 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.7631 pure
CY2021 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.1029 pure
CY2020 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.3048 pure
CY2019 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.4259 pure
CY2024Q1 us-gaap Assets Net
AssetsNet
200000 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1300000 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30600000 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
94800000 usd
CY2020Q4 us-gaap Assets Net
AssetsNet
102100000 usd
CY2019Q4 us-gaap Assets Net
AssetsNet
127100000 usd
CY2024Q1 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
1.4095 pure
CY2023 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.1191 pure
CY2022 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.031 pure
CY2019 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.028 pure
CY2024Q1 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-1.229 pure
CY2023 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-0.1099 pure
CY2022 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-0.2096 pure
CY2021 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.0294 pure
CY2020 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.0064 pure
CY2019 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.036 pure
CY2019 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0564 pure
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4695742 usd
CY2024Q1 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
-4527822 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
167920 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8733779 usd
CY2023Q4 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
-7473408 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<b>USE OF ESTIMATES.</b> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CONCENTRATION OF CREDIT RISK. </b>The Company places its cash and cash equivalents with financial institutions and, at times, cash held in checking accounts <em style="font: inherit;"> may </em>exceed the Federal Deposit Insurance Corporation insured limit.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q1 svvc Deferred Compensation Arrangement Percent Of Compensation Deferred
DeferredCompensationArrangementPercentOfCompensationDeferred
0.50 pure
CY2024Q1 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
0 usd
CY2024Q1 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
129141664 usd
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-129141664 usd
CY2024Q1 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
133837406 usd
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698 pure
CY2024Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3465923 usd
CY2024Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
9161034 usd
CY2024Q1 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
35040442 usd
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47667399 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47667399 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12387144 usd
CY2023 svvc Operating Loss Carryforwards Period
OperatingLossCarryforwardsPeriod
P5Y
CY2024Q1 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
100000 usd

Files In Submission

Name View Source Status
0001437749-24-016607-index-headers.html Edgar Link pending
0001437749-24-016607-index.html Edgar Link pending
0001437749-24-016607.txt Edgar Link pending
0001437749-24-016607-xbrl.zip Edgar Link pending
ex_623243.htm Edgar Link pending
ex_623244.htm Edgar Link pending
ex_623245.htm Edgar Link pending
ex_623246.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
i46.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sccv20240331_10q.htm Edgar Link pending
Show.js Edgar Link pending
sig01.jpg Edgar Link pending
svvc-20240331.xsd Edgar Link pending
svvc-20240331_def.xml Edgar Link unprocessable
svvc-20240331_lab.xml Edgar Link unprocessable
svvc-20240331_pre.xml Edgar Link unprocessable
sccv20240331_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
svvc-20240331_cal.xml Edgar Link unprocessable